NCT02649504 Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia Status WITHDRAWN Phase PHASE3
NCT02642380 Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP) Status WITHDRAWN Phase PHASE4
NCT02566603 PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP Status TERMINATED Phase PHASE1/PHASE2
NCT02556814 Caffeic Acid Combining High-dose Dexamethasone in Management of ITP Status COMPLETED Phase PHASE4
NCT02401061 PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP Status TERMINATED Phase PHASE1/PHASE2
NCT02391272 A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy Status COMPLETED Phase PHASE3
NCT02338414 An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP Status UNKNOWN Phase PHASE2
NCT02298075 Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia Status COMPLETED Phase N/A
NCT02287649 Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP) Status COMPLETED Phase NA
NCT02279173 Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP) Status COMPLETED Phase PHASE3
NCT02270801 Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in Pregnancy Status UNKNOWN Phase PHASE3
NCT02203422 A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia (ITP) Status WITHDRAWN Phase PHASE3
NCT02153060 An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP) Status COMPLETED Phase PHASE2
NCT02139501 An Investigation of rhTPO With Different Frequencies in the Management of ITP Status COMPLETED Phase PHASE3
NCT02137681 A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia (ITP) Status WITHDRAWN Phase PHASE3
NCT02063789 An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia Status COMPLETED Phase PHASE3
NCT01976195 High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP Status WITHDRAWN Phase PHASE2